Title |
Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
|
---|---|
Published in |
BMC Pharmacology and Toxicology, January 2013
|
DOI | 10.1186/2050-6511-14-6 |
Pubmed ID | |
Authors |
Mariel Núñez, Vanina Medina, Graciela Cricco, Máximo Croci, Claudia Cocca, Elena Rivera, Rosa Bergoc, Gabriela Martín |
Abstract |
Glibenclamide (Gli) binds to the sulphonylurea receptor (SUR) that is a regulatory subunit of ATP-sensitive potassium channels (KATP channels). Binding of Gli to SUR produces the closure of KATP channels and the inhibition of their activity. This drug is widely used for treatment of type 2-diabetes and it has been signaled as antiproliferative in several tumor cell lines. In previous experiments we demonstrated the antitumoral effect of Gli in mammary tumors induced in rats. The aim of the present work was to investigate the effect of Gli on MDA-MB-231 breast cancer cell proliferation and to examine the possible pathways involved in this action. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Brazil | 1 | 2% |
Unknown | 62 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 15 | 23% |
Researcher | 10 | 16% |
Student > Master | 9 | 14% |
Student > Doctoral Student | 7 | 11% |
Student > Bachelor | 4 | 6% |
Other | 8 | 13% |
Unknown | 11 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 16 | 25% |
Biochemistry, Genetics and Molecular Biology | 13 | 20% |
Medicine and Dentistry | 6 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
Immunology and Microbiology | 2 | 3% |
Other | 7 | 11% |
Unknown | 15 | 23% |